
GC16957
Src I1
Also known as 6,7-dimethoxy-N-(4-phenoxyphenyl)quinazolin-4-amine
Src I1 is a potent, ATP-competitive and selective dual site Src tyrosine kinase inhibitor with IC50 values of 44 nM for Src and 88nM for Lck
ChemicalCAS179248-59-0MW373.4FormulaC22H19N3O3
- CAS number
- 179248-59-0
- Molecular weight
- 373.4
- Formula
- C22H19N3O3
- Solubility
- DMF: 0·25 mg/ml,DMF:PBS(pH7·2) (1:2): 0·33 mg/ml,DMSO: 2·5 mg/ml
- InChIKey
- DMWVGXGXHPOEPT-UHFFFAOYSA-N
- Catalogue number
- GC16957
- Brand
- GLPBIO
Computed properties PubChem CID 1474853 · XLogP 4.9 · TPSA 65.5 Ų · H-bond donors 1
- XLogP
- 4.9
- TPSA
- 65.5 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 6
- Heavy atoms
- 28
SMILES COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)OC4=CC=CC=C4)OC
Computed descriptors from PubChem (CID 1474853), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il